A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session3da22656ec98f0667dac36112b0082849e41135f): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Drug of Abuse (DOA) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

img

Global Drug of Abuse (DOA) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Drug of Abuse (DOA) Testing Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

The drug of abuse test is an immunoassay based on the principle of competitive binding. 
Global Drug of Abuse (DOA) Testing market is projected to reach US$ 9703.7 million in 2033, increasing from US$ 6321 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2033. Demand from Hospitals and Laboratories are the major drivers for the industry.
North America will dominate the drug of abuse testing market in 2022 owing to high R&D investment, presence of global players, increasing adoption of technologically advanced solutions, and efforts of major companies. In North America, the U.S. accounted for the major share accounting for 90% owing to the rise in the use of illicit drugs and the resulting increase in health problems. Rising monitoring of illicit drug consumption in the workplace and rise in drug trafficking are other factors contributing to the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Drug of Abuse (DOA) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Segment by Type
Urine
Saliva
Hair
Others

Segment by Application


Hospitals
Laboratories
Workplace
At-Home
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Drug of Abuse (DOA) Testing market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Drug of Abuse (DOA) Testing introduction, etc. Drug of Abuse (DOA) Testing Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Drug of Abuse (DOA) Testing market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Drug of Abuse (DOA) Testing
1.1 Drug of Abuse (DOA) Testing Market Overview
1.1.1 Drug of Abuse (DOA) Testing Product Scope
1.1.2 Drug of Abuse (DOA) Testing Market Status and Outlook
1.2 Global Drug of Abuse (DOA) Testing Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Drug of Abuse (DOA) Testing Market Size by Region (2018-2033)
1.4 Global Drug of Abuse (DOA) Testing Historic Market Size by Region (2018-2023)
1.5 Global Drug of Abuse (DOA) Testing Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Drug of Abuse (DOA) Testing Market Size (2018-2033)
1.6.1 North America Drug of Abuse (DOA) Testing Market Size (2018-2033)
1.6.2 Europe Drug of Abuse (DOA) Testing Market Size (2018-2033)
1.6.3 Asia-Pacific Drug of Abuse (DOA) Testing Market Size (2018-2033)
1.6.4 Latin America Drug of Abuse (DOA) Testing Market Size (2018-2033)
1.6.5 Middle East & Africa Drug of Abuse (DOA) Testing Market Size (2018-2033)
2 Drug of Abuse (DOA) Testing Market by Type
2.1 Introduction
2.1.1 Urine
2.1.2 Saliva
2.1.3 Hair
2.1.4 Others
2.2 Global Drug of Abuse (DOA) Testing Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Drug of Abuse (DOA) Testing Revenue Breakdown by Type (2018-2033)
3 Drug of Abuse (DOA) Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Laboratories
3.1.3 Workplace
3.1.4 At-Home
3.1.5 Others
3.2 Global Drug of Abuse (DOA) Testing Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Drug of Abuse (DOA) Testing Revenue Breakdown by Application (2018-2033)
4 Drug of Abuse (DOA) Testing Competition Analysis by Players
4.1 Global Drug of Abuse (DOA) Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2022)
4.3 Date of Key Players Enter into Drug of Abuse (DOA) Testing Market
4.4 Global Top Players Drug of Abuse (DOA) Testing Headquarters and Area Served
4.5 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Drug of Abuse (DOA) Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Siemens
5.1.1 Siemens Profile
5.1.2 Siemens Main Business
5.1.3 Siemens Drug of Abuse (DOA) Testing Products, Services and Solutions
5.1.4 Siemens Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Siemens Recent Developments
5.2 Merck
5.2.1 Merck Profile
5.2.2 Merck Main Business
5.2.3 Merck Drug of Abuse (DOA) Testing Products, Services and Solutions
5.2.4 Merck Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Merck Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Drug of Abuse (DOA) Testing Products, Services and Solutions
5.3.4 Roche Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Thermo Fisher Scientific Recent Developments
5.4 Thermo Fisher Scientific
5.4.1 Thermo Fisher Scientific Profile
5.4.2 Thermo Fisher Scientific Main Business
5.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Products, Services and Solutions
5.4.4 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Thermo Fisher Scientific Recent Developments
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business
5.5.3 Bio-Rad Drug of Abuse (DOA) Testing Products, Services and Solutions
5.5.4 Bio-Rad Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Bio-Rad Recent Developments
5.6 Abbott
5.6.1 Abbott Profile
5.6.2 Abbott Main Business
5.6.3 Abbott Drug of Abuse (DOA) Testing Products, Services and Solutions
5.6.4 Abbott Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Abbott Recent Developments
5.7 Quest Diagnostics
5.7.1 Quest Diagnostics Profile
5.7.2 Quest Diagnostics Main Business
5.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Products, Services and Solutions
5.7.4 Quest Diagnostics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Quest Diagnostics Recent Developments
5.8 Psychemedics
5.8.1 Psychemedics Profile
5.8.2 Psychemedics Main Business
5.8.3 Psychemedics Drug of Abuse (DOA) Testing Products, Services and Solutions
5.8.4 Psychemedics Drug of Abuse (DOA) Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Psychemedics Recent Developments
6 North America
6.1 North America Drug of Abuse (DOA) Testing Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug of Abuse (DOA) Testing Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug of Abuse (DOA) Testing Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug of Abuse (DOA) Testing Market Dynamics
11.1 Drug of Abuse (DOA) Testing Industry Trends
11.2 Drug of Abuse (DOA) Testing Market Drivers
11.3 Drug of Abuse (DOA) Testing Market Challenges
11.4 Drug of Abuse (DOA) Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Drug of Abuse (DOA) Testing Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Drug of Abuse (DOA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Drug of Abuse (DOA) Testing Market Size Share by Region (2018-2023)
Table 4. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Drug of Abuse (DOA) Testing Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Drug of Abuse (DOA) Testing Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Drug of Abuse (DOA) Testing Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2023)
Table 9. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Drug of Abuse (DOA) Testing Revenue Market Share by Type (2024-2033)
Table 11. North America Drug of Abuse (DOA) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Drug of Abuse (DOA) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Drug of Abuse (DOA) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Drug of Abuse (DOA) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Drug of Abuse (DOA) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Drug of Abuse (DOA) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Drug of Abuse (DOA) Testing Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Drug of Abuse (DOA) Testing Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Drug of Abuse (DOA) Testing Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Drug of Abuse (DOA) Testing Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2023)
Table 24. Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Drug of Abuse (DOA) Testing Revenue Market Share by Application (2024-2033)
Table 26. North America Drug of Abuse (DOA) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Drug of Abuse (DOA) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Drug of Abuse (DOA) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Drug of Abuse (DOA) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Drug of Abuse (DOA) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Drug of Abuse (DOA) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Drug of Abuse (DOA) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Drug of Abuse (DOA) Testing Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Drug of Abuse (DOA) Testing Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Drug of Abuse (DOA) Testing Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2022)
Table 39. Date of Key Players Enter into Drug of Abuse (DOA) Testing Market
Table 40. Global Drug of Abuse (DOA) Testing Key Players Headquarters and Area Served
Table 41. Drug of Abuse (DOA) Testing Product Solution and Service
Table 42. Global Drug of Abuse (DOA) Testing Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Siemens Basic Information List
Table 45. Siemens Description and Business Overview
Table 46. Siemens Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 47. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Siemens (2018-2023)
Table 48. Siemens Recent Developments
Table 49. Merck Basic Information List
Table 50. Merck Description and Business Overview
Table 51. Merck Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 52. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Merck (2018-2023)
Table 53. Merck Recent Developments
Table 54. Roche Basic Information List
Table 55. Roche Description and Business Overview
Table 56. Roche Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 57. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Roche (2018-2023)
Table 58. Roche Recent Developments
Table 59. Thermo Fisher Scientific Basic Information List
Table 60. Thermo Fisher Scientific Description and Business Overview
Table 61. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 62. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Thermo Fisher Scientific (2018-2023)
Table 63. Thermo Fisher Scientific Recent Developments
Table 64. Bio-Rad Basic Information List
Table 65. Bio-Rad Description and Business Overview
Table 66. Bio-Rad Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 67. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Bio-Rad (2018-2023)
Table 68. Bio-Rad Recent Developments
Table 69. Abbott Basic Information List
Table 70. Abbott Description and Business Overview
Table 71. Abbott Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 72. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Abbott (2018-2023)
Table 73. Abbott Recent Developments
Table 74. Quest Diagnostics Basic Information List
Table 75. Quest Diagnostics Description and Business Overview
Table 76. Quest Diagnostics Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 77. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Quest Diagnostics (2018-2023)
Table 78. Quest Diagnostics Recent Developments
Table 79. Psychemedics Basic Information List
Table 80. Psychemedics Description and Business Overview
Table 81. Psychemedics Drug of Abuse (DOA) Testing Products, Services and Solutions
Table 82. Revenue (US$ Million) in Drug of Abuse (DOA) Testing Business of Psychemedics (2018-2023)
Table 83. Psychemedics Recent Developments
Table 84. North America Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 86. Europe Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 88. Asia-Pacific Drug of Abuse (DOA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 89. Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Drug of Abuse (DOA) Testing Market Size by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Region (2018-2023)
Table 92. Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Region (2024-2033)
Table 93. Latin America Drug of Abuse (DOA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 96. Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 97. Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Drug of Abuse (DOA) Testing Market Size by Country (2024-2033) & (US$ Million)
Table 99. Drug of Abuse (DOA) Testing Market Trends
Table 100. Drug of Abuse (DOA) Testing Market Drivers
Table 101. Drug of Abuse (DOA) Testing Market Challenges
Table 102. Drug of Abuse (DOA) Testing Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug of Abuse (DOA) Testing Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Drug of Abuse (DOA) Testing Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Drug of Abuse (DOA) Testing Market Share by Regions: 2022 VS 2033
Figure 4. Global Drug of Abuse (DOA) Testing Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Drug of Abuse (DOA) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Drug of Abuse (DOA) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Drug of Abuse (DOA) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Drug of Abuse (DOA) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Urine
Figure 11. Global Urine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Saliva
Figure 13. Global Saliva Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Hair
Figure 15. Global Hair Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Drug of Abuse (DOA) Testing Market Size Share by Type: 2022 & 2033
Figure 19. North America Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2033)
Figure 20. Europe Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Drug of Abuse (DOA) Testing Revenue Market Share by Type (2018-2033)
Figure 24. Hospitals Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Laboratories Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Workplace Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. At-Home Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 28. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 29. Global Drug of Abuse (DOA) Testing Market Size Share by Application: 2022 & 2033
Figure 30. North America Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2033)
Figure 31. Europe Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2033)
Figure 32. Asia-Pacific Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2033)
Figure 33. Latin America Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2033)
Figure 34. Middle East and Africa Drug of Abuse (DOA) Testing Revenue Market Share by Application (2018-2033)
Figure 35. Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 36. Global Top 5 and Top 10 Players Drug of Abuse (DOA) Testing Market Share in 2022
Figure 37. North America Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 38. U.S. Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 39. Canada Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 40. Germany Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 41. France Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 42. U.K. Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 43. Italy Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 44. Russia Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 45. Nordic Countries Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 46. Asia-Pacific Drug of Abuse (DOA) Testing Market Share by Region (2018-2033)
Figure 47. China Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 48. Japan Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 49. South Korea Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 50. Southeast Asia Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 51. India Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 52. Australia Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 53. Latin America Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 54. Mexico Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 55. Brazil Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 56. Middle East & Africa Drug of Abuse (DOA) Testing Market Share by Country (2018-2033)
Figure 57. Turkey Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 58. Saudi Arabia Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 59. UAE Drug of Abuse (DOA) Testing Market Size (2018-2033) & (US$ Million)
Figure 60. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries